$6861.T

Keyence Q1 Net Income Rises

Keyence (6861.T) reported Q1 net income attributable to parent of 139.1 billion yen, up 51% year over year. EPS rose to 573.69 yen from 379.82 yen. Operating income increased 44.7% to 187.8 billion yen, and ordinary income rose 49.6% to 196.8 billion yen. Net sales for the three months ended June 20, 2026 were 346.6 billion yen, up 32.8%.

Original reporting
Published Jul 28, 2026, 8:45 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 28, 2026, 10:03 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Keyence Q1 Net Income Rises — source image
Decision brief

The 30-second read

$6861.TBullishMed
01

Why it matters

The disclosed earnings datapoints can drive near-term repricing versus prior expectations, but the absence of guidance and consensus context reduces the ability to quantify surprise.

02

Market read

Traders can use the reported YoY growth in net income and net sales to reassess earnings momentum for Keyence, but there is no forward-looking catalyst in the text.

03

What to watch

No breakdown by end-market, no margin/FCF discussion, and no outlook commentary are provided, which are key for assessing whether the growth is sustainable.

Relevance 6/10Novelty 6/10Timing: Q1 results reported for the three months ended June 20, 2026, with shares noted at the time of publication.

Background

The piece summarizes Keyence’s first-quarter financial performance and provides the reported share price level on the Tokyo Stock Exchange.

Company-level read

Ticker impact

$6861.TBullishMedium confidence
Context

Keyence reported Q1 net income of 139.1B yen, up 51% YoY, with net sales up 32.8% YoY for the three months ended June 20, 2026.

Expected impact

Near-term bias is likely positive as the print shows strong YoY growth across income lines and sales.

Evidence & confidence

All reported figures show substantial YoY increases, which typically supports earnings momentum, though the article provides no guidance or consensus comparison to gauge surprise magnitude.

Market effects

Strong growth at a leading automation/sensing name can reinforce positive sentiment toward industrial automation demand, though the article is single-company focused.

Supports Japan large-cap earnings momentum and may influence local peers’ sentiment in industrial tech.

Limited direct global read-through without guidance or segment detail, but it can contribute to broader industrial automation earnings expectations.

Counterpoint

Without consensus estimates, margins, or forward guidance, the market may already be positioned for growth, limiting incremental upside.

Key entities

  • Keyence Corporation

    Reported Q1 net income, EPS, operating income, ordinary income, and net sales for the three months ended June 20, 2026.

Related articles

$LLYMedAI 8/10

Eli Lilly and Company Q2 Earnings Call Highlights

Eli Lilly (LLY) reported Q2 U.S. revenue up 33% led by ZEPBOUND and MOUNJARO volume, while U.S. price fell 3% (9% excluding rebate and discount estimate changes). International revenue rose in constant currency, with MOUNJARO a key driver. Lilly raised its 2026 revenue outlook to $85B-$87B and guided non-GAAP EPS $35.50-$36.50. It also discussed Medicare GLP-1 coverage expansion and retatrutide Phase III results.

$BRK-BMed

Berkshire Hathaway Just Did Something It Hasn’t Done in More Than 3 Years

Berkshire Hathaway reported Q2 2026 cash and Treasury bills of $365.5 billion, down from $397.4 billion in Q1, ending a 14-quarter streak as a net seller. According to Berkshire, CEO Greg Abel became a net buyer of equities, adding about $20 billion net, and increased buybacks to $4.5 billion. Apple fell to 20% of the portfolio; Alphabet rose after a $10 billion investment.

$LIONMed

Lionsgate Studios Q1 Earnings Call Highlights

Lionsgate (NYSE:LION) Q1 earnings call said it expects downstream revenue from films through fiscal 2027 and that The Hunger Games: Sunrise on the Reaping could support later-year results. Television revenue was $189 million, segment profit $10 million. Trailing 12-month library revenue was $987 million, backlog $1.5 billion. Net debt fell $121 million to about $1.5 billion; leverage improved to 4.3x.

$ENBMed

Enbridge Delivers Strong Q2 Results: Is the Stock Still a Buy?

Enbridge reported Q2 2026 results, with adjusted earnings of $1.4B, or $0.63 per share, roughly matching last year’s $0.65. Adjusted EBITDA rose to $4.8B from $4.6B. Operating cash flow increased to $4.1B from $3.2B. The company reaffirmed full-year guidance, added $1B to a $41B growth backlog, sanctioned Line 5 relocation and signed an option for the TTC Connector Pipeline.

$LEUMedAI 8/10

Centrus Energy Q2 Earnings Call Highlights

Centrus Energy (NYSE: LEU) said it met financial contingencies tied to its LEU enrichment backlog, covering over $3 billion in customer contracts. It reported Q2 revenue of $153.4 million in LEU, up 22%, and reaffirmed 2026 guidance of $450 million to $500 million revenue and $350 million to $500 million capex. Centrus added a $900 million DOE task order and completed HALEU requirements early.

$LCIIMedAI 8/10

LCI Industries Q2 Earnings Call Highlights

LCI Industries (NYSE:LCII) reported Q2 margin gains, citing cost actions and sourcing improvements. OEM adjusted operating margin rose to 7.5%, and aftermarket adjusted operating margin reached 14%. LCI expects FY revenue $3.9B-$4.1B, adjusted EPS $8.25-$8.75, and RV wholesale shipments 280k-300k. It expects nearly $90M tariff refunds passed through to customers and maintained a 7.5%-8% operating margin target.